Clinical Oncology Society of Australia
Welcome
to COSA
COSA is the peak national body for all health professionals whose work involves the care of cancer patients.
San Antonio Breast Cancer Symposium 2023
VIEW EVENTS CALENDARBecome a member
With professional and financial benefits, there are many reasons to join COSA.
Join TodayCollaborate and make a difference
Join likeminded health professionals working across all cancers to impact cancer care and control.
VIEW OUR GROUPS
Why become
a member?
The benefits of membership are both professional and financial.
Become a Member
Online access to the Asia Pacific Journal of Clinical Oncology & many other publications
Member BenefitsUpcoming
events



16/05/2023 - 19/05/2023
ALLG May 2023 Scientific Meeting
Australasia Leukaemia and Lymphoma Group
VIEW EVENT


15/06/2023 - 17/06/2023
International Symposium on Late Complications After Childhood Cancer
VIEW EVENT
Education
COSA supports the professional and educational needs of its members by designing, developing and delivering professional development activities. Examples of these activities include the ASM, Clinical Professional Days, the Cancer Care Coordination Conference and the development of Clinical Practice Guidelines.
Research
COSA facilitates research across the spectrum of cancer care through the ASM, COSA Groups and support for the Cancer Cooperative Trials Groups. COSA also publishes submissions and reports related to cancer research issues in Australia.
Advocacy
COSA is active in advocating for improvements in cancer care policy in Australia. COSA regularly makes submissions to government and other organisations on matters of significance to COSA members. COSA also releases reports and position statements developed by COSA members.
Collaboration
COSA works to enhance cancer care in Australia through the development of professional networks. COSA members with a common interest in a discipline, disease type or area of need form Groups to discuss issues and develop solutions to common problems in cancer care.
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology yesterday
COSA's Cancer Pharmacists Group has an updated Position Statement on the safe handling of monoclonal antibodies in healthcare settings. 14 recommendations to lower occupational risks when handling mABs. Now available for download from our website. https://t.co/IgTu8s3QOG https://t.co/yfGMOH6NrH
Read More >
COSAoncology yesterday
COSA's 2022 update to the safe handling of monoclonal antibodies in healthcare settings. Published earlier this month, and now available for download from our website. 14 recommendations to lower occupational risk for Practitioners when handling mABs. https://t.co/zKsiW7OK00
Read More >
COSAoncology yesterday
As well as COSA's overview of last year, our 2022 Annual Report contains reviews of achievements and activities of our Groups and Affiliated Organisations. Now available on our website: https://t.co/peLSjh0gEu https://t.co/gykKvdD6OH
Read More >
COSAoncology 3 days ago
March edition of COSA eNews is out today! COSA members get monthly email news covering latest papers, resources and opportunities. https://t.co/K0Ykio6Ihh https://t.co/ADr5KYfDxF
Read More >
COSAoncology 8 days ago
Great to see the COSA Council well underway ... https://t.co/J5JN3PRBEB
Read More >
COSAoncology 10 days ago
COSA Members: we want your feedback. What should we keep doing? Stop doing? Start doing? Please check your email inbox for the link to our 10-minute survey. https://t.co/6xExJkQjXF
Read More >
COSAoncology 10 days ago
COSA Retweeted @TOGAANZ: The program for #TOGAASM23 is now available https://t.co/PvvA0ROASl F2f Int'l speakers incl @sgswisher & @karenkellymd present…
Read More >
COSAoncology 11 days ago
Earlybird registrations now open for the 15th Foundation Clinical Practice Course for Cancer Pharmacists. Develop foundational skills in providing cancer treatment to patients, with focus on the management of key tumour groups. Sydney, 24-25 June https://t.co/6UIPBZk0qu https://t.co/GTIcyuGDgr
Read More >
COSAoncology 16 days ago
We'll be posting this position statement on the COSA website shortly.
Read More >
COSAoncology 16 days ago
COSA Retweeted @bogda_koczwara: Just published: our paper on #comorbidity management in #breast cancer: ✅89% had comorbidities ✅many #comorbidities in…
Read More >